FIELD: chemistry.
SUBSTANCE: method to manufacture benzyldimethyl[3-(myristoilamino)propyl]ammonium chloride monohydrate-С26Н47ClN2О·Н2О implies two stages, which are reacting myristic acid followed by the end product formation at the second stage. 3-dimethylaminopropylamide is obtained at the first stage by direct reaction of myristic acid with 3-dimethylaminopropylamine in aromatic hydrocarbons, while end product is obtained at the second stage by direct benzylation in alcohols or ketones.
EFFECT: improved purity of end product and process safety.
3 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRODUCING BENZYLDIMETHYL[3-(MYRISTOYLAMINO)-PROPYL]AMMONIUM CHLORIDE MONOHYDRATE AND PHARMACEUTICAL SUBSTANCE BASED THEREON | 2018 |
|
RU2678093C1 |
| METHOD FOR PRODUCING BENZYLDIMETHYL[3-(MYRISTOYLAMINO)PROPYL]AMMONIUM CHLORIDE MONOHYDRATE | 2023 |
|
RU2812562C1 |
| USE OF BENZYLDIMETHYL[3-(STEARINOYLAMINO)PROPYL] AMMONIUM CHLORIDE AS AN ANTIBACTERIAL AND/OR ANTISEPTIC AGENT AND METHOD OF ITS OBTAINING | 2022 |
|
RU2808635C1 |
| METHOD FOR PRODUCING BENZYLDIMETHYL[3-(MYRISTOYLAMINO)PROPYL]AMMONIUM CHLORIDE MONOHYDRATE | 2022 |
|
RU2802627C1 |
| CRYSTALLINE B-MODIFICATION OF BENZYLDIMETHYL[3- (MYRISTOYLAMINO)PROPYL]AMMONIUM OF MONOHYDRATE CHLORIDE, METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2016 |
|
RU2626877C1 |
| DERIVATIVES OF DODECANOIC ACID, WHICH HAVE ANTISEPTIC ACTION | 2007 |
|
RU2353612C2 |
| ANTISEPTIC ON THE BASIS OF DODECANIC ACID | 2016 |
|
RU2655603C1 |
| DRUG | 2020 |
|
RU2776367C2 |
| THERAPEUTIC COMPOSITION FOR THE TREATMENT OF OTITIS MEDIA WITH PERFORATION OF THE TYMPANIC MEMBRANE | 2022 |
|
RU2782926C1 |
| ANTISEPTIC COMBINATION, ANTISEPTIC PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | 2021 |
|
RU2774622C1 |
